Search

Your search keyword '"Field, Thalia S."' showing total 371 results

Search Constraints

Start Over You searched for: Author "Field, Thalia S." Remove constraint Author: "Field, Thalia S." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
371 results on '"Field, Thalia S."'

Search Results

2. Specialist Perspectives on the Imaging Selection of Large Vessel Occlusion in the Late Window

4. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

5. External validation of the SI2NCAL2C score for outcomes following cerebral venous thrombosis

7. Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study

10. Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus Tenecteplase

14. Neuroimaging standards for research into small vessel disease—advances since 2013

15. Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis

16. Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial

18. Management of blunt cerebrovascular injuries at a Canadian level 1 trauma centre: Are we meeting the grade?

20. Infarcts in a New Territory: Insights From the ESCAPE-NA1 Trial

21. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

27. Reducing the global burden of cerebral venous thrombosis: An international research agenda

28. An interrupted time-series analysis of the impact of COVID-19 on hospitalizations for vascular events in three Canadian provinces

31. Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial

33. Contributors

35. Prevalence of Walking Limitation After Acute Stroke and Its Impact on Discharge to Home

36. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase

37. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis

38. A Randomized Controlled Trial of Tenecteplase Versus Standard of Care for Minor Ischemic Stroke with Proven Occlusion (TEMPO-2): Rational and design of a multicenter, randomized open-label clinical trial.

39. Effect of incomplete reperfusion patterns on clinical outcome: insights from the ESCAPE-NA1 trial.

40. Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke.

42. Abstract TMP14: Population-Based Intracranial Vascular Imaging for Acute Ischemic Stroke is Suboptimal

43. Abstract TMP108: External Validation of the SI 2 NCAL 2 C Score for Mortality Following Cerebral Venous Thrombosis

45. Abstract WMP11: Intravenous Thrombolysis in Patients Without versus With Visible Occlusion: A Secondary Analysis From the AcT Trial

46. Infarct Evolution on MR-DWI After Thrombectomy in Acute Stroke Patients Randomized to Nerinetide or Placebo

48. Reshaping the path of vascular cognitive impairment with progressive resistance training: A 12‐Month Randomized Trial

Catalog

Books, media, physical & digital resources